Latest News about ZYME
Recent news which mentions ZYME
5 Value Stocks In The Healthcare Sector
July 24, 2023
From Benzinga
2 Biotech Stocks That Could Make You Richer
July 14, 2023
From Motley Fool
From InvestorPlace
From Benzinga
From InvestorPlace
3 Cheap Growth Stocks That Are Too Good to Pass Up
June 05, 2023
From InvestorPlace
5 Value Stocks In The Healthcare Sector
May 29, 2023
From Benzinga
Top 5 Health Care Stocks That May Collapse In Q2
May 10, 2023
From Benzinga
Earnings Scheduled For May 8, 2023
May 08, 2023
From Benzinga
The 7 Most Undervalued Stocks You Need to Know About
April 18, 2023
From InvestorPlace
Overview Of Value Stocks In The Healthcare Sector
April 10, 2023
From Benzinga
Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact
March 20, 2023
From Benzinga
Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
March 08, 2023
From Benzinga
From Benzinga
Jazz Pharma, Zymeworks Highlight 84% Overall Survival At 18 Months From Zanidatamab In Esophageal Cancer
January 19, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 19, 2023
From Benzinga
Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
January 19, 2023
From Benzinga
From InvestorPlace
Around $10M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
January 19, 2023
From Benzinga
From Benzinga
Alphabet To $115? Here Are 10 Other Price Target Changes For Thursday
December 22, 2022
From Benzinga
Tesla, Amazon, Micron, Sintx, Zymeworks: Why These 5 Stocks Are Drawing Investors' Attention Today
December 21, 2022
From Benzinga
Jazz Pharma Opts In, Advances Zanidatamab Partnership With Zymeworks
December 21, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.